AP Biosciences Total Current Liabilities

AP Biosciences (6945.TWO) currently reports a total current liabilities of $39M as of June 2026. That compares with $28M in the prior-year period — up 37.6% year over year. Use the charts on this page to explore AP Biosciences's total current liabilities history and peer comparisons.

AP Biosciences's total current liabilities increased from $28M to $39M — a 37.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AP Biosciences reported $39M in total current liabilities as of June 2026. That compares with $28M in the prior-year period — up 37.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $39M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AP Biosciences, and consider following 6945.TWO for alerts when major investors trade the stock.

AP Biosciences is classified in the Healthcare sector. On total current liabilities, it currently shows $39M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6945.TWO with unrelated industries.